Search

everythinglearnresearchcommunity

for

Search:↓

Studying rare genetic disorders can help us understand and treat common diseases better.

Botulinum toxin type A helps treat hair loss by stopping cell death in hair follicles through a process involving certain non-coding RNAs and a protein called Bax.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Keratin gel may help repair damaged nerves.

A new treatment for hair loss uses tiny lipid carriers to deliver a mix of minoxidil and latanoprost directly to hair follicles, promoting hair growth and being well tolerated by the skin.

Targeting the MC-5-HT-HTR2A axis may help treat chronic itching.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Acid can block TRPV3 from outside the cell but boost its function from inside.

Amlodipine impairs fertility in male rats by affecting sperm and testicular structure.

Thai plant extracts, especially Avicennia marina, can promote hair growth by inhibiting certain enzymes and boosting growth factors.

The new hair loss treatment combining nitric oxide and minoxidil in a special carrier is effective for hair regrowth.

Scale created to measure hair loss in men and women; MK-386 reduces acne; Niaspan treats dyslipidemia; minoxidil increases heart rate.

FGF9 from certain cells can trigger new hair growth during wound healing, but humans have fewer of these cells, which may limit hair regrowth.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

One minoxidil-sensitive potassium channel exists in human hair follicles.

The growth factor cocktail with FGF9 significantly increased hair density and diameter in patients with androgenetic alopecia.

Botox is effective for urinary incontinence, chronic migraines, and male pattern hair loss, and a new test for Botox antibodies is more humane.

Chewing betel nut may increase the risk of type 2 diabetes, and saw palmetto can improve urinary symptoms in BPH with fewer side effects but may cause bleeding and allergic reactions.

The S9 fraction with GC-IDMS is effective for measuring 5α-reductase activity.

The 1% ethyl acetate fraction ethosomal gel from Nothopanax scutellarium leaves promotes hair growth but can mildly irritate the skin.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Brimonidine is effective for reducing facial redness in skin conditions and has potential for broader dermatological uses.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

HSD11b1 affects skin nerves and increases non-histaminergic itch.

Neuromyotonia and morphoea can occur together in the same body areas.